Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $33.27 (+25.8%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/14/2013 BofA/Merrill Lynch Downgrade Neutral
(Buy)
N/A
(N/A)
32.01 26.44 -17.4% Details
6/14/2013 RBC Capital Downgrade Sector Perform
(Outperform)
32.00
(N/A)
32.01 26.44 -17.4% Details
6/14/2013 JMP Securities Upgrade Market Outperform
(Market Perform)
48.00
(N/A)
32.01 26.44 -17.4% Details
6/13/2013 Leerink Swann Downgrade Market Perform
(Outperform)
39.00
(N/A)
33.92 26.44 -22.05% Details
6/7/2013 Canaccord Genuity New Coverage Buy
(N/A)
40.00
(N/A)
31.06 26.44 -14.87% Details
5/31/2013 Jefferies
» Updated 6/14/2013
Downgrade Hold
(Buy)
31.00
(N/A)
32.17 26.44 -17.81% Details
5/9/2013 Stephens New Coverage Overweight
(N/A)
38.00
(N/A)
30.63 26.44 -13.68% Details
5/8/2013 Mizuho Securities Upgrade Buy
(Neutral)
34.00
(27.00)
28.30 26.44 -6.57% Details
2/5/2013 Ladenburg Thalmann Downgrade Neutral
(Buy)
N/A
(N/A)
26.92 26.44 -1.78% Details
1/3/2013 JPMorgan Downgrade Underweight
(Neutral)
26.00
(26.00)
27.68 26.44 -4.48% Details
12/3/2012 Goldman Sachs
» Updated 4/10/2013
Downgrade Neutral
(Buy)
27.00
(N/A)
28.72 26.44 -7.94% Details
10/2/2012 Cowen New Coverage Outperform
(N/A)
N/A
(N/A)
27.40 26.44 -3.5% Details
10/1/2012 Piper Jaffray
» Updated 6/13/2013
Upgrade Overweight
(Neutral)
49.00
(39.00)
26.95 26.44 -1.89% Details
9/25/2012 Credit Suisse New Coverage Neutral
(N/A)
28.00
(N/A)
27.05 26.44 -2.26% Details
6/18/2012 Dougherty & Co Downgrade Neutral
(Buy)
22.00
(28.00)
23.68 26.44 11.66% Details
Like MYGN Ratings? Also take a look at GENE, DVA, BIO, GHDX

MYGN Ratings News